CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test Read more

Awards & Recognition

The honors we receive help power us forward. We’re truly humbled by the recognition.
Can you help us push further? Careers

Awards

International Design Excellence Awards

Category: Lifestyle & Accessories > Silver Award > Visby Medical COVID-19 Test

Organizer: IDSA.org (Industrial Designers Society of America)

Fast Company’s 2021 Innovation by Design Awards

Visby Medical COVID-19 Test:

Grants

Up to $48.7 MM BARDA Funding

Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, power development of a rapid Flu-COVID PCR test designed for at-home use.

$10.0 MM NIH RADx Funding

Phase 2 funding was awarded to Visby Medical from the National Institutes of Health (NIH) as a part of the Rapid Acceleration of Diagnostics (RADx) initiative. The RADx initiative aims to combat SARS-CoV-2 and increase national testing capacity for COVID-19.

$19.0 million awarded by NIH/BARDA/HHS to combat antibiotic resistance

Visby Medical, Inc., was awarded $19 million as a prize for its winning diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea and rapidly determining in under 30 minutes if the microorganism is susceptible to a single-dose antibiotic.